Oragenics (OGEN) Tax Rate (2010 - 2026)
Oragenics' (OGEN) quarterly Tax Rate came in at 1.02% in Q1 2026, down 93.49% on a QoQ basis from 15.63% in Q4 2018.
Oragenics (OGEN) Tax Rate (2010 - 2026) Analysis & Trends
Oragenics (OGEN) has 10 years of Tax Rate data on file, last reported at 1.02% in Q1 2026.
- Quarterly Tax Rate changed N/A year-over-year to 1.02% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 4.55% (changed N/A YoY) and the FY2025 annual result came in at 1.37%, up 138.0% from the prior year.
- Tax Rate eased to 1.02% in Q1 2026, from 15.63% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 1.02% in Q1 2026 to a low of 1.02% in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.91% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 24.15% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 7.49% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -16.71% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 34.12% |
| 10 | Oragenics | 2.38 Mn | 2.38 Mn | - | 1.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.80% |
| Jun 30, 2026 | 1.80% |
| Jun 30, 2026 | 1.80% |
| Mar 31, 2026 | 1.02% |
| Mar 31, 2026 | 1.02% |
| Mar 31, 2026 | 1.02% |
| Dec 31, 2018 | 15.63% |
| Dec 31, 2018 | 15.63% |
| Dec 31, 2018 | 15.63% |
| Mar 31, 2017 | -0.06% |
| Mar 31, 2017 | -0.06% |
| Mar 31, 2017 | -0.06% |
| Dec 31, 2016 | 9.48% |
| Dec 31, 2016 | 9.48% |
| Dec 31, 2016 | 9.48% |
| Sep 30, 2016 | 0.12% |
| Sep 30, 2016 | 0.12% |
| Sep 30, 2016 | 0.12% |
| Jun 30, 2016 | -0.07% |
| Jun 30, 2016 | -0.07% |